Viewing nowCombinationAbatril Tablet 5/160/20 milligrams
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.

MFDS item code 202006661 · Approved 2020.09.25 · Insurance code 669908050
Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with combined amlodipine/valsartan therapy, and for those requiring atorvastatin to reduce the risk of cardiovascular diseases. Amlodipine and valsartan help control blood pressure, while atorvastatin reduces the risk of cardiovascular diseases such as myocardial infarction, stroke, and angina, and improves dyslipidemia. It is particularly effective in reducing the risk of cardiovascular diseases in adults with multiple risk factors or a history of heart disease, as well as in patients with type 2 diabetes. Additionally, it helps to regulate cholesterol and triglyceride levels in patients with dyslipidemia. Therefore, this medication is used to improve cardiovascular health by managing both blood pressure and lipid levels simultaneously.
Take 1 tablet once daily with water. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking the amlodipine/valsartan combination together with atorvastatin as separate tablets may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of the individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Before and during treatment with atorvastatin, patients should follow a standard cholesterol-lowering diet. Atorvastatin may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not possible. - Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. - Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult population.
This medication may cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. If there are any unusual muscle-related symptoms or a significant increase in creatine kinase levels in blood tests, the use of this medication should be stopped. This medication should not be administered to patients with specific diseases or conditions, including those with severe liver or kidney disease, pregnant or lactating women, and patients with hypersensitivity. When administered to patients who are deficient in sodium or body fluids, there is a risk of severe hypotension, so caution is needed, and appropriate measures should be taken immediately if symptoms of hypotension occur. Patients with elevated potassium levels may experience further increases in potassium levels, requiring regular blood tests. In patients with impaired renal function or kidney transplant recipients, use of this medication is limited or requires caution. In patients with heart failure or after myocardial infarction, renal function and blood pressure status should be closely monitored; it should be used cautiously in patients with acute myocardial infarction as symptoms may worsen. Dizziness or fatigue may occur during treatment with this medication; therefore, caution should be taken when driving or operating machinery. Due to numerous drug interactions, patients should consult with their physician or pharmacist when taking this medication alongside other drugs, especially when combined with certain antibiotics, antifungals, or immunosuppressants. This medication can cause various side effects, including liver dysfunction, myalgia, skin rashes, and gastrointestinal symptoms; patients should report any unusual symptoms to medical personnel immediately. Women of childbearing age must use appropriate contraception while taking this medication, and those who plan to become pregnant or are pregnant should consult with medical personnel. Lactating women should avoid taking this medication, and alternative treatment methods should be considered if necessary. Before taking this medication, patients must inform their doctor of their medical history and any other medications they are taking, and regular checks should be performed to ensure safe treatment.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the medication for a longer period.
Pale pink oval film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.